| Product NDC: | 0555-0617 |
| Proprietary Name: | Pramipexole Dihydrochloride |
| Non Proprietary Name: | Pramipexole Dihydrochloride |
| Active Ingredient(s): | .125 mg/1 & nbsp; Pramipexole Dihydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0555-0617 |
| Labeler Name: | Barr Laboratories Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA077724 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20100104 |
| Package NDC: | 0555-0617-62 |
| Package Description: | 63 TABLET in 1 BOTTLE (0555-0617-62) |
| NDC Code | 0555-0617-62 |
| Proprietary Name | Pramipexole Dihydrochloride |
| Package Description | 63 TABLET in 1 BOTTLE (0555-0617-62) |
| Product NDC | 0555-0617 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Pramipexole Dihydrochloride |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20100104 |
| Marketing Category Name | ANDA |
| Labeler Name | Barr Laboratories Inc. |
| Substance Name | PRAMIPEXOLE DIHYDROCHLORIDE |
| Strength Number | .125 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Dopamine Agonists [MoA],Nonergot Dopamine Agonist [EPC] |